Teva, Allergan settle Rhode Island opioid suit for $107M: 3 notes

Allergan and Teva Pharmaceuticals have settled allegations that they helped fuel Rhode Island’s opioid epidemic, state Attorney General Peter Neronha said March 21.

Advertisement

Three notes:

1. As part of the settlement, the drugmakers will pay the state a combined $28.5 million in cash over the next 13 years.

2. They’ll also give Rhode Island 1 million doses of naloxone, which can be used to reverse the effects of an opioid overdose, and 67,000 30-pill bottles of Suboxone, a medication used to treat opioid use disorder, in various doses for free over the next 10 years.

3. The deal results in a combined settlement value of $107 million. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.